Targeting human TLRs to combat COVID-19: A solution?

J Med Virol. 2021 Feb;93(2):615-617. doi: 10.1002/jmv.26387. Epub 2020 Aug 13.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Actin Depolymerizing Factors
  • CD4-Positive T-Lymphocytes
  • COVID-19*
  • Cell Movement
  • HIV Infections*
  • Humans
  • Immune Reconstitution*
  • SARS-CoV-2

Substances

  • Actin Depolymerizing Factors